FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 8.29 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $70,046,000 | +319.4% | 1,859,461 | +89.4% | 0.00% | +300.0% |
Q4 2020 | $16,703,000 | +395.8% | 981,924 | +37.0% | 0.00% | – |
Q3 2020 | $3,369,000 | -17.8% | 716,824 | +6.7% | 0.00% | – |
Q2 2020 | $4,098,000 | +193.6% | 671,840 | +9.2% | 0.00% | – |
Q1 2020 | $1,396,000 | -51.5% | 615,025 | -1.8% | 0.00% | – |
Q4 2019 | $2,876,000 | +11.9% | 626,555 | -5.5% | 0.00% | – |
Q3 2019 | $2,571,000 | -36.3% | 663,359 | -0.8% | 0.00% | – |
Q2 2019 | $4,034,000 | -77.0% | 669,035 | -49.0% | 0.00% | -100.0% |
Q1 2019 | $17,569,000 | +48.4% | 1,311,113 | +3.0% | 0.00% | 0.0% |
Q4 2018 | $11,840,000 | -44.1% | 1,273,135 | -16.3% | 0.00% | -50.0% |
Q3 2018 | $21,183,000 | -29.7% | 1,521,721 | -20.2% | 0.00% | -33.3% |
Q2 2018 | $30,132,000 | -13.4% | 1,906,183 | -5.8% | 0.00% | 0.0% |
Q1 2018 | $34,781,000 | -9.0% | 2,024,585 | +16.2% | 0.00% | 0.0% |
Q4 2017 | $38,210,000 | -7.4% | 1,742,994 | +72.8% | 0.00% | -25.0% |
Q3 2017 | $41,268,000 | +1.2% | 1,008,777 | -25.5% | 0.00% | 0.0% |
Q2 2017 | $40,782,000 | -9.7% | 1,354,597 | +8.4% | 0.00% | 0.0% |
Q1 2017 | $45,175,000 | -9.3% | 1,249,520 | +25.7% | 0.00% | -20.0% |
Q4 2016 | $49,809,000 | -10.6% | 994,032 | -6.3% | 0.01% | -16.7% |
Q3 2016 | $55,691,000 | +27.3% | 1,061,061 | +0.3% | 0.01% | +20.0% |
Q2 2016 | $43,741,000 | +30.8% | 1,057,836 | +28.5% | 0.01% | +25.0% |
Q1 2016 | $33,443,000 | +24.1% | 823,188 | +26.8% | 0.00% | +33.3% |
Q4 2015 | $26,950,000 | +15.9% | 649,350 | -57.0% | 0.00% | 0.0% |
Q3 2015 | $23,260,000 | -35.0% | 1,511,246 | +4.9% | 0.00% | -25.0% |
Q2 2015 | $35,783,000 | +40.5% | 1,440,588 | +29.3% | 0.00% | +33.3% |
Q1 2015 | $25,468,000 | +352.9% | 1,114,514 | +435.5% | 0.00% | +200.0% |
Q4 2014 | $5,623,000 | +153.7% | 208,131 | +10.1% | 0.00% | – |
Q3 2014 | $2,216,000 | -17.3% | 189,016 | +9.7% | 0.00% | – |
Q2 2014 | $2,680,000 | +64.8% | 172,366 | +108.6% | 0.00% | – |
Q1 2014 | $1,626,000 | +131.0% | 82,649 | +97.2% | 0.00% | – |
Q4 2013 | $704,000 | – | 41,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|